Literature DB >> 17379492

Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.

Junyang Xu1, Fengxia Jiang, Fariba Nayeri, Olle Zetterström.   

Abstract

BACKGROUND: Eosinophilic inflammation of the airways is a key characteristic of asthma. A defect in eosinophil apoptosis might contribute to the chronic tissue eosinophilia associated with asthma.
OBJECTIVE: Our purpose was to examine whether the occurrence of apoptotic eosinophils in induced sputum from asthmatic patients correlate with interleukin (IL)-5 and eotaxin.
METHODS: Thirty stable and 30 exacerbated asthmatic patients were recruited. Twenty healthy subjects were enrolled as a control group. Induced sputum was obtained from asthmatic patients and from control subjects. The number of apoptotic eosinophils in sputum was assessed by flow cytometry. In sputum supernatant, eosinophil cationic protein (ECP) was measured by sensitive radioimmunoassay, and IL-5 and eotaxin by sandwich enzyme linked immunosorbant assay.
RESULTS: Levels of eosinophils, apoptotic eosinophils, IL-5, ECP and eotaxin from asthmatic patients were higher than those from healthy subjects. Thirty exacerbated asthmatics showed higher proportions of eosinophils (median 29.3%, range 13.4%-40.9%), more detectable levels of IL-5 (50.44, 32.99-67.01 pg/ml) and eotaxin (644.6, 197.4-937.7 pg/ml) in their sputum than the patients with stable asthma (P<0.05). There were significant inverse correlations between the levels of sputum IL-5 and the proportion of sputum eosinophil apoptosis in patients with exacerbated and stable asthma (r=-0.85 and -0.79, P<0.01 and P<0.05, respectively). Also inverse correlations were found between the levels of eotaxin and the proportion of sputum eosinophil apoptosis in exacerbated (r=-0.85, P<0.01), or stable asthma (r=-0.69, P<0.05). Additional positive correlations between the levels of sputum IL-5 and eotaxin in either exacerbatated (r=0.93, P<0.01) or stable asthma (r=0.82, P<0.05) were observed.
CONCLUSIONS: Apoptosis of eosinophils might be suppressed by proinflammatory cytokines and chemokines such as IL-5 and eotaxin leading to their accumulation in the lung. Stimulation of eosinophils in airway with IL-5 and eotaxin may play a crucial role in allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379492     DOI: 10.1016/j.rmed.2007.01.026

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  11 in total

1.  The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.

Authors:  Chang K Kim; Hirohito Kita; Zak Callaway; Hyo B Kim; Jungi Choi; Takao Fujisawa; Bo M Shin; Young Y Koh
Journal:  Pediatr Allergy Immunol       Date:  2010-04-27       Impact factor: 6.377

Review 2.  Novel Biological Therapies for Severe Asthma Endotypes.

Authors:  Corrado Pelaia; Giulia Pelaia; Claudia Crimi; Angelantonio Maglio; Anna Agnese Stanziola; Cecilia Calabrese; Rosa Terracciano; Federico Longhini; Alessandro Vatrella
Journal:  Biomedicines       Date:  2022-05-04

Review 3.  Which biomarkers are effective for identifying Th2-driven inflammation in asthma?

Authors:  Zuzana Diamant; Ellen Tufvesson; Leif Bjermer
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 4.  Effects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysis.

Authors:  Thiago Mamôru Sakae; Rosemeri Maurici; Daisson José Trevisol; Marcia Margaret Menezes Pizzichini; Emílio Pizzichini
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 5.  Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.

Authors:  Corrado Pelaia; Alessandro Vatrella; Maria Teresa Busceti; Luca Gallelli; Rosa Terracciano; Rocco Savino; Girolamo Pelaia
Journal:  Drug Des Devel Ther       Date:  2017-10-30       Impact factor: 4.162

6.  Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Authors:  Marie-Chantal Larose; Anne-Sophie Archambault; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  Front Med (Lausanne)       Date:  2017-08-11

Review 7.  Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview.

Authors:  M Hassani; L Koenderman
Journal:  Allergy       Date:  2018-10-08       Impact factor: 13.146

Review 8.  Interleukin-5 in the Pathophysiology of Severe Asthma.

Authors:  Corrado Pelaia; Giovanni Paoletti; Francesca Puggioni; Francesca Racca; Girolamo Pelaia; Giorgio Walter Canonica; Enrico Heffler
Journal:  Front Physiol       Date:  2019-12-17       Impact factor: 4.566

Review 9.  Molecular Targets for Biological Therapies of Severe Asthma.

Authors:  Corrado Pelaia; Claudia Crimi; Alessandro Vatrella; Caterina Tinello; Rosa Terracciano; Girolamo Pelaia
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

Review 10.  Role of biologics in severe eosinophilic asthma - focus on reslizumab.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Maria Teresa Busceti; Luca Gallelli; Mariaimmacolata Preianò; Nicola Lombardo; Rosa Terracciano; Rosario Maselli
Journal:  Ther Clin Risk Manag       Date:  2016-07-01       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.